Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,345 | 42,965 | 34,992 | 21,661 | 25,886 |
| Marketable Securities | N/A | 2,431 | 13,493 | 36,978 | 36,875 |
| Receivables | 25,069 | 9,983 | 14,410 | 18,981 | 14,014 |
| Inventories | 19,560 | 18,900 | 16,294 | 13,884 | 14,998 |
| TOTAL | $122,663 | $78,450 | $82,433 | $96,096 | $96,554 |
| Non-Current Assets | |||||
| PPE Net | 7,531 | 7,865 | 8,143 | 8,056 | 8,396 |
| Intangibles | 149,410 | 151,972 | 154,940 | 150,308 | 153,108 |
| Other Non-Current Assets | 43,373 | 44,061 | 44,703 | 10,352 | 11,336 |
| TOTAL | $200,314 | $203,898 | $207,786 | $168,716 | $172,840 |
| Total Assets | $322,977 | $282,348 | $290,219 | $264,812 | $269,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,971 | 9,384 | 9,440 | 5,152 | 5,339 |
| Accrued Expenses | 9,122 | 6,757 | 5,616 | 5,160 | 8,621 |
| TOTAL | $42,791 | $38,348 | $35,364 | $32,821 | $33,366 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,436 | 14,279 | 12,667 | 11,803 | 11,938 |
| Other Non-Current Liabilities | 93,264 | 93,690 | 93,992 | 58,717 | 54,785 |
| TOTAL | $128,213 | $111,281 | $113,359 | $78,379 | $73,423 |
| Total Liabilities | $171,004 | $149,629 | $148,723 | $111,200 | $106,789 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,119 | 71,316 | 70,706 | 70,446 | 69,565 |
| Common Shares | 74 | 71 | 71 | 70 | 70 |
| Retained earnings | -658,735 | -652,736 | -639,721 | -623,641 | -610,956 |
| Other shareholders' equity | -289 | -809 | -885 | -582 | -758 |
| TOTAL | $151,973 | $132,719 | $141,496 | $153,612 | $162,605 |
| Total Liabilities And Equity | $322,977 | $282,348 | $290,219 | $264,812 | $269,394 |